Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Riboflavin 5'-Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 1/20 | 0.85 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.85 |
| ▸ | FDPS known ✓ | P14324 | 1/20 | 0.30 |
| ▸ | TST | Q16762 | 2/20 | 0.98 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.98 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.98 |
| ▸ | ESR1 | P03372 | 1/20 | 0.85 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.85 |
| ▸ | HTR2C | P28335 | 1/20 | 0.85 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.85 |
| ▸ | MEN1 | O00255 | 7/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.70 |
| ▸ | USP2 | O75604 | 4/20 | 0.70 |
| ▸ | HTT | P42858 | 4/20 | 0.70 |
| ▸ | HAT1 | O14929 | 4/20 | 0.70 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | RECQL | P46063 | 3/20 | 0.70 |
| ▸ | CASP7 | P55210 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin 5'-Phosphate SCHEMBL623880 | 1.00 | TST (0.98) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL8656633 | 1.00 | TST (0.98) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29738641 | 0.99 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL1232070 | 0.99 | TST (0.97) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29456702 | 0.99 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29839430 | 0.99 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL21899339 | 0.99 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL1078313 | 0.97 | TST (0.92) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL19816821 | 0.97 | TST (0.92) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL195609 | 0.95 | TST (0.88) | TSTHSPD1HSPE1ESR1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11032 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219735-B1 | METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR | ABBOTT DIABETES CARE (US) | 2026-04-01 | — | — | EP | claimed |
| US-12569403-B2 | Capsule with reduced powder leakage | CAPSUGEL BELGIUM NV (BE) | 2026-03-10 | — | — | US | claimed |
| US-20260061056-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | MANA HEALTH TECHNOLOGIES GMBH (AT) | 2026-03-05 | — | — | US | claimed |
| EP-4649136-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| WO-2025103503-A1 | SULFONE-BASED HYDROCARBON MEMBRANES WITH DECENTRALIZED ION-TRANSPORT CHANNELS AND CARBON COATING FOR A POLYSULFIDE-BASED REDOX FLOW BATTERY | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-05-22 | — | — | WO | claimed |
| WO-2025085404-A1 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR TREATING LUNG CANCER | GENENTECH, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| EP-4525996-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | Mana Health Technologies GmbH (AT) | 2025-03-26 | — | — | EP | claimed |
| EP-4069178-B1 | CAPSULE WITH REDUCED POWDER LEAKAGE | CAPSUGEL BELGIUM NV (BE) | 2025-03-12 | — | — | EP | claimed |
| WO-2025049283-A2 | ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-03-06 | — | — | WO | claimed |
| US-20240404707-A1 | MACHINE LEARNING-BASED SYSTEMS AND METHODS FOR PREDICTING LIVER CANCER RECURRENCE IN LIVER TRANSPLANT PATIENTS | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2024-12-05 | — | — | US | claimed |
| EP-0217748-B1 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1991-02-06 | — | — | EP | claimed |
| EP-0214908-B1 | COMPOUNDS CONTAINING AN OLIGONUCLEOTIDE SEQUENCE LINKED TO AN INTERCALATING AGENT AND TO AN ACTIVABLE CHEMICAL GROUP, THEIR SYNTHESIS AND APPLICATIONS TO ARTIFICIAL SEQUENCE-SPECIFIC NUCLEASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1990-11-07 | — | — | EP | claimed |
| EP-0144218-B1 | ECL GATE ARRAY | FUJITSU LIMITED (JP) | 1990-09-05 | — | — | EP | claimed |
| EP-0373002-A2 | Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract | ALLERGAN, INC (US) | 1990-06-13 | — | — | EP | claimed |
| EP-0279461-A2 | Immunological method for the determination of antigens or antibodies in biological fluids, and dyes therefor | IDT AG FUR IN VIVO DIAGNOSTIK UND THERAPIE (CH) | 1988-08-24 | — | — | EP | claimed |
| WO-1988002785-A2 | IMPROVED NUCLEIC ACID HYBRIDIZATION TECHNIQUE AND KIT THEREFOR | BECKMAN INSTRUMENTS, INC. (US) | 1988-04-21 | — | — | WO | claimed |
| EP-0231605-A2 | Riboflavin production with yeast | ZeaGen, Inc. (US) | 1987-08-12 | — | — | EP | claimed |
| EP-0214908-A1 | Compounds containing an oligonucleotide sequence linked to an intercalating agent and to an activable chemical group, their synthesis and applications to artificial sequence-specific nucleases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-18 | — | — | EP | claimed |
| EP-0179786-A1 | HIGH COPY NUMBER EXPRESSION VECTORS. | BIOGEN NV (NL) | 1986-05-07 | — | — | EP | claimed |
| WO-1985004419-A1 | HIGH COPY NUMBER EXPRESSION VECTORS | BIOGEN N.V. (AN) | 1985-10-10 | — | — | WO | claimed |